← Open Payments lookup

RENATA CASTELO: Open Payments

NPI 1831750249 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,209 in 38 payments from 23 companies in 2025. Trend: 2023 $751 · 2024 $849 · 2025 $1,209

Food & beverage: $1,123Education: $86
CompanyPaymentsAmount
Daiichi Sankyo Inc.4$173
AstraZeneca Pharmaceuticals LP2$146
Astellas Pharma US Inc4$108
E.R. Squibb & Sons, L.L.C.1$100
Takeda Pharmaceuticals U.S.A., Inc.2$71
ABBVIE INC.3$69
Genmab U.S., Inc.2$56
Merck Sharp & Dohme LLC2$52
GENZYME CORPORATION2$43
Caris MPI, Inc.1$33

Products named: DATROWAY, ENHERTU, REBLOZYL, Xtandi, FRUZAQLA, RUBRACA, AYVAKIT, IMBRUVICA.

Industry payments across TX — which companies pay providers there.